This bill introduces new reporting requirements for participants in the 340B Drug Pricing Program, mandating that 340B covered entities provide detailed annual data to the Department of Health and Human Services and the Department of Justice. The required information includes the entity's name, service address, 340B Program Identification Number, acquisition costs for prescription drugs, payments received, charity care costs, and the number of patients sent to collections. The Department of Health and Human Services is tasked with aggregating this data and reporting it to the general court by November 15 each year. The bill also establishes penalties for non-compliance, including fines for late submissions and categorizing certain violations as unfair or deceptive trade practices. To implement these changes, the bill inserts new provisions related to the assessment and preparation for hearings regarding RSA 7:24 violations into RSA 126-A, while removing outdated references to previous assessment protocols. It defines key terms such as "340B Covered Entity," "charity care," and "financially indigent," and outlines the responsibilities of the Department of Justice in reviewing compliance with charitable obligations. The act is set to take effect on January 1, 2027, and while it does not provide funding or authorize new positions, it is anticipated that the Department of Justice will require additional personnel to manage the increased workload, with estimated costs projected at $398,000 in FY27, $402,000 in FY28, and $408,000 in FY29.